Competitive CDMRP award funds preclinical programs against two cryptic cell-surface targets discovered directly in patient tumors using the company’s AI-powered RyboCypher™ platform and CypherAtlas™ knowledgebase SAN DIEGO, July 9, 2026 /PRNewswire/ — RyboDyn, Inc., a biotechnology…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
